Recovery act tissue samples and data from various types of cancer for the cancer genome atlas (tcga) program arra::yes::arra
Ended Awarded Last action
- Contract number
- HHSN261201000050I
- Awardee
-
Mayo Clinic UEI Y2K4F9RPRRG7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $130,403 obligated
Award facts
- Opportunity
-
- RECOVERY - Tissue Purchase Order Contract Acquisitions for NCI's The Cancer Genome Atlas Program Award Notice · Posted Dec 4, 2009
- Combined order value
- $130,403 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 24% used
- $539,649.40
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Mayo Clinic, a renowned non-profit academic medical center. The contract, valued at $130,403.07, supports the NCI's Cancer Genome Atlas (TCGA) program by recovering tissue samples and data from various types of cancer. It is part of a larger $9.9 million NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract, which allows the NCI to efficiently access Mayo Clinic's expertise in cancer research and drug development over multiple years.
Through this contract, Mayo Clinic provides critical support to the NCI's Experimental Therapeutics program, including conducting bioanalytical testing and pharmacokinetic assessments to aid in the development and FDA approval of new cancer treatments. The contract has a period of performance from June 2010 to March 2015 and does not have a set-aside designation, reflecting Mayo Clinic's status as a large institution. This contract vehicle enables the NCI to leverage Mayo Clinic's extensive expertise in clinical care, research, and education to advance the agency's initiatives in cancer research and treatment.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Recovery act tissue samples and data from various types of cancer for the cancer genome atlas (tcga) program… | National Cancer Institute (NIH) | $130,403 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201000050I?
HHSN261201000050I was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on June 25, 2010.
How much is contract HHSN261201000050I worth?
Orders under HHSN261201000050I have obligated $130,403. HHSN261201000050I's own ceiling is $539,649.
How many orders have been placed under contract HHSN261201000050I?
1 order has been placed under HHSN261201000050I, the latest on June 29, 2010.
Who can order from contract HHSN261201000050I?
HHSN261201000050I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201000050I part of a contract vehicle?
Yes. HHSN261201000050I is part of NCI Cancer Genome Atlas Program Tissue Purchase.
Was contract HHSN261201000050I competed?
The extent of competition for HHSN261201000050I was competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV